Looking around at the hundreds of orchids in bloom on the back patio of her Weston home, Sara Singer is hard-pressed to pick a favorite from her beloved collection. There are the highly prized ...
Step 3: Search it up When a botanist suspects a species is new to science, it's the start of a long journey to find out. The team began a search to compare the orchid from Norfolk Island with ...
Orchid Security, an emerging leader in identity-first security orchestration, today announced it has raised $36 million in seed funding. Co-led by Team8 and Intel Capital, with the support of ...
WASHINGTON, Jan. 8, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) letter to FDA Commissioner highlights faulty gastroparesis NDA review. Vanda Logo (PRNewsfoto/Vanda ...
After Vanda Pharmaceuticals’ phase 3 miss and FDA rejection for its stomach disorder candidate, CEO Mihael Polymeropoulos, M.D., is calling out the regulatory agency for a “disturbing pattern ...
Vanda Pharma VNDA has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below summarizes their recent ratings ...
The FDA has declined to approve Vanda Pharma's tradipitant for delayed gastric emptying (gastroparesis), prompting a furious response from the company. In a statement, the company says the FDA's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback